The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Investigation Report on China's Irbesartan Market, 2018-2022
US$ 2,200.00
... of China's Irbesartan market Market demand for Irbesartan in China Analysis on competition on China's Irbesartan market Analysis on major Irbesartan manufacturers in China Driving forces for China's Irbesartan market from 2018 to 2022 Prospect of China's Irbesartan ...
September 2018
30 pages
Investigation Report on China's Lamivudine Market, 2018-2022
US$ 2,200.00
... : Development environment of China's Lamivudine market Size of China's Lamivudine market Competition pattern of China's Lamivudine market Prices of Lamivudine in China Driving forces and opportunities for China's Lamivudine market Prospect of China's Lamivudine market from ...
September 2018
30 pages
Investigation Report on China's Sildenafil Market, 2018-2022
US$ 2,200.00
... the approval. Therefore, Chinese manufacturers began to launch Sildenafil in 2014. CRI's market investigation shows that China's Sildenafil market is dominated by Pfizer's Viagra, Baiyunshan's Jinge ...
September 2018
30 pages
Drug-Device Combination Products Market by Product (Drug-eluting Stent, Infusion Pump, Photodynamic Therapy, Antimicrobial Wound Dressing, Prefilled Syringe, Drug-eluting Balloon, Nebulizer, Inhaler, Transdermal Delivery System, and Others), Application (Cardiovascular Treatment, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Others), and End User (Hospital & Clinic, Ambulatory Surgical Center, Home Care Setting, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025
US$ 5,370.00
... the growth of the global drug-device combination products market. Further, rise in geriatric population, technological advancements in drug-device combination product, and surge in homebased healthcare market are the other factors ...
September 2018
244 pages
Orphan Drug Market - Forecasts from 2018 to 2023
US$ 3,950.00
The orphan drug market is projected to grow at a CAGR of 10.94% to reach US$285.799 billion in 2023 from US$153.275 billion in 2017. During the forecast period, prescription sales ...
August 2018
108 pages
Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Market Forecast to 2023
US$ 2,000.00
... “Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Market Forecast to 2023”, the Global Antibody Drug Conjugates ... and advances in linking technologies, for the Global Antibody Drug Conjugates Market. Furthermore, the report also gives information ...
August 2018
110 pages
Aspergillosis Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Aspergillosis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Aspergillosis pipeline products. DISEASE OVERVIEW Aspergillus is a general fungus type that causes ...
August 2018
90 pages
Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
... is the main challenge in detecting and treating Burkholderia Infections disease. Individuals with low immunity levels and ... Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Burkholderia ...
August 2018
45 pages
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chagas Disease (American trypanosomiasis) pipeline products. DISEASE OVERVIEW Chagas disease, also known as American Trypanosomiasis, is one of the ...
August 2018
70 pages
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chikungunya (CHIKV) Infection pipeline products. DISEASE OVERVIEW Chikungunya fever is a viral fever, caused ...
August 2018
90 pages
Chlamydia Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Chlamydia Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chlamydia pipeline products. DISEASE OVERVIEW Chlamydia infections are caused by Chlamydia trachomatis bacteria. Worldwide, the ...
August 2018
60 pages
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptosporidiosis (crypto) pipeline products. DISEASE OVERVIEW Cryptosporidium is one of the most widespread intestinal ...
August 2018
30 pages
Diphtheria Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Diphtheria Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Diphtheria pipeline products. DISEASE OVERVIEW Global Diphtheria market is estimated to be around $4.5 billion in 2020 driven ...
August 2018
60 pages
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products. DISEASE OVERVIEW The disease is primarily ...
August 2018
35 pages
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease ...
August 2018
50 pages
Herpes Labialis Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection impacting ...
August 2018
35 pages
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...
August 2018
40 pages
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...
August 2018
90 pages
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...
August 2018
90 pages
Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...
August 2018
30 pages
Rabies Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...
August 2018
60 pages
Rotavirus Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...
August 2018
45 pages
Rubella (German measles) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...
August 2018
30 pages
Tetanus Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...
August 2018
65 pages
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...
August 2018
35 pages
Yellow Fever Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...
August 2018
40 pages
Global High BP/Hypertension Drugs and Device Market Forecast 2018-2023
US$ 3,600.00
... /Hypertension drugs monitoring Device Market Research and Analysis, By Drugs 3. Global High blood pressure/Hypertension drugs monitoring Device Market Research and Analysis, By Monitoring Devices 4. Global High blood pressure/Hypertension drugs ...
August 2018
-
Investigation Report on Chinese Insulin Glargine Market, 2018-2022
US$ 2,200.00
... of Insulin Glargine Supply of and demand for Insulin Glargine in China Major Insulin Glargine manufacturers in China Prices of Insulin Glargine in China Factors influencing the development of the Chinese Insulin Glargine market from 2018 to 2022 Prospect of the Chinese Insulin Glargine ...
August 2018
30 pages
Investigation Report on Chinese Ossotide Market, 2018-2022
US$ 2,200.00
... years. TOPICS COVERED: Development environment of Ossotide Sales of Ossotide in China Competition pattern of Chinese Ossotide Market Major Ossotide manufacturers in China Prices of Ossotide in China Prospect of the Chinese Ossotide market from 2018 to 2022
August 2018
30 pages
Probiotics - Global Market Outlook (2017-2026)
US$ 4,150.00
According to Stratistics MRC, the Global Probiotics market is accounted for $42.64 billion in 2017 and is expected to reach $87.91 billion by 2026 ... across the western countries and technological advancements in probiotic products are propelling the market growth. In addition, government support and rising ...
July 2018
211 pages
Global Drug Eluting Stents Market 2018-2024
US$ 3,250.00
... regulatory approval process are hampering the growth of the market. Market Analysis: The “global drug-eluting stents market” is estimated to witness a CAGR of 5.4% during the forecast period 2018 ...
July 2018
110 pages
Global Orphan Drugs Market: Industry Analysis & Outlook (2018-2022)
US$ 1,000.00
... improving healthcare facilities. The global orphan drugs market is expected to grow in future due to prolonged orphan drug market exclusivity, increasing sales of prescription drugs, attractive orphan drug policies, rising healthcare expenditure ...
July 2018
79 pages
Global Cardiovascular Drug Market Research and Forecast 2018-2023
US$ 3,600.00
... government policies impacting the Global Cardiovascular drug market. Insights about market determinants which are stimulating the Global Cardiovascular drug market. Detailed and extensive market segments with regional distribution ...
July 2018
-
Investigation Report on Chinese Rituximab Market, 2018-2022
US$ 2,200.00
... growth potential for the Chinese Rituximab market. Topics Covered: Development environment of Chinese Rituximab market Sales of Rituximab in China Prices of Rituximab in China Progress of generic Rituximab in China Prospects of Chinese Rituximab Market, 2018-2022
July 2018
30 pages
Investigation Report on Chinese Epoetin Alfa Market, 2018-2022
US$ 2,200.00
... and the increase of residents' income. Topics Covered: Development environment of Epoetin Alfa in China Demand for Epoetin Alfa in China Major Epoetin Alfa Manufacturers in China Prices of Epoetin Alfa in China Prospects of Chinese Epoetin Alfa Market
July 2018
30 pages
Global Respiratory Drug Market Research and Forecast 2018-2023
US$ 3,600.00
... : Global Respiratory drug market Research and Analysis, By Drug Global Respiratory drug market Research and Analysis, By Drug Class Global Respiratory drug market Research and Analysis, By Route of Administration Global Respiratory drug market Research and Analysis, By End User Global Respiratory drug market ...
July 2018
-
Investigation Report on Chinese Imatinib Market, 2018-2022
US$ 2,200.00
... environment of Imatinib in China Forecast on market size of Imatinib in China Market share of major Imatinib manufacturers in China Retail prices of Imatinib in China Development of generic Imatinib in China India-made Imatinib smuggled to China Prospects of Chinese Imatinib market, 2018 ...
July 2018
30 pages
Investigation Report on Chinese Latanoprost Market, 2018-2022
US$ 2,200.00
... -operative medications, and thus a high demand for Latanoprost in China. Topics Covered: Development environment of Latanoprost in China Sales of Latanoprost in China Major Latanoprost manufacturers in China Retail prices of Latanoprost in China Prospects of Chinese Latanoprost market
July 2018
30 pages
Investigation Report on Chinese Sorafenib Market, 2018-2022
US$ 2,200.00
... that China-made Sorafenib will appear on the market after 2022. Topics Covered: Sales of Sorafenib in China Prices of Sorafenib in China Sales of Sorafenib in China by region Sales of India-made Sorafenib in China Prospects of Chinese Sorafenib ...
July 2018
30 pages
Investigation Report on Chinese Thymosin ?1 Market, 2018-2022
US$ 2,200.00
... China, with its sales value increasing from less than CNY 7 million in 2015 to more than CNY 1.2 billion in 2017. The Chinese Thymosin ... Size of Chinese Thymosin α1 market Competition pattern of the Chinese Thymosin α1 market Prices in the Chinese Thymosin α1 market Prospects of the Chinese Thymosin α1 market
July 2018
30 pages
Global 3D Printed Drugs Market Research and Forecast 2018-2027
US$ 3,600.00
... government policies impacting the global 3D Printed Drugs Market Insights about market determinants which are stimulating the global 3D Printed Drugs Market Detailed and extensive market segments with regional distribution ...
July 2018
-
Investigation Report on Chinese Thymopentin Market, 2018-2022
US$ 2,200.00
... are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug. According to CRI, in 2017, the ... sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by ...
July 2018
30 pages
Investigation Report on Chinese Deproteinized Calf Blood Extractives Market, 2018-2022
US$ 2,200.00
... Chinese Deproteinized Calf Blood Extractives market Size of the Chinese Deproteinized Calf Blood Extractives market Competition pattern of the Chinese Deproteinized Calf Blood Extractives market Prices in the Chinese Deproteinized Calf Blood Extractives market Forecast on the Chinese Deproteinized Calf Blood ...
July 2018
30 pages
Investigation Report on Chinese Ioversol Market, 2018-2022
US$ 2,200.00
... exceeded 90% in 2017. Topics Covered: Development history of Ioversol in China Size of China Ioversol market Competition Pattern of Chinese Ioversol market Prices in the Chinese Ioversol market Prospects of Chinese Ioversol Market, 2018-2022
July 2018
30 pages
